Treatment for MBC focuses on prolonging survival and elevating quality of life through specific approaches tailored to the pathological characteristics of the cancer, hormone receptor (HR), human epidermal growth factor receptor 2 (HER2) status, and other factors. Here, ERBB2 is linked to cancer.